Kirk Coleman - Tff Pharmaceuticals Treasurer CFO
Insider
Kirk Coleman is Treasurer CFO of Tff Pharmaceuticals
| Age | 50 |
| Phone | 817 438 6168 |
| Web | https://tffpharma.com |
Tff Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.0591) % which means that it has lost $1.0591 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1351) %, meaning that it created substantial loss on money invested by shareholders. Tff Pharmaceuticals' management efficiency ratios could be used to measure how well Tff Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Tff Pharmaceuticals currently holds 115.25 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Tff Pharmaceuticals has a current ratio of 8.02, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Tff Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Kishor Bhatia | Lantern Pharma | 70 | |
| Brian JD | Tscan Therapeutics | 55 | |
| Tomasz Kula | Tscan Therapeutics | N/A | |
| Gavin MacBeath | Tscan Therapeutics | 54 | |
| Natalia PerezCarmona | Gain Therapeutics | N/A | |
| Salvatore Calabrese | Gain Therapeutics | 54 | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Reid McCarthy | Annovis Bio | 66 | |
| Steven Almo | Cue Biopharma | 64 | |
| Pamela Garzone | Anixa Biosciences | 70 | |
| Sanjay Chanda | AN2 Therapeutics | 60 | |
| Michael Hoffman | Annovis Bio | 69 | |
| Ray Lockard | Tscan Therapeutics | N/A | |
| Manolo Bellotto | Gain Therapeutics | 53 | |
| Ana GarciaCollazo | Gain Therapeutics | N/A | |
| Dennis Giesing | Immunome | 72 | |
| Stephen Elledge | Tscan Therapeutics | N/A | |
| Sandra Esq | Immunome | 51 | |
| Trishna MD | In8bio Inc | 45 | |
| Kenneth LaMontagne | In8bio Inc | N/A | |
| Andrew CPA | Cognition Therapeutics | 64 | |
Management Performance
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 |
Tff Pharmaceuticals Leadership Team
Elected by the shareholders, the Tff Pharmaceuticals' board of directors comprises two types of representatives: Tff Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tff. The board's role is to monitor Tff Pharmaceuticals' management team and ensure that shareholders' interests are well served. Tff Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tff Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harlan Weisman, Interim Chairman | ||
| Zamaneh MD, Chief Officer | ||
| Kirk Coleman, Treasurer CFO | ||
| Paul Manley, Head Affairs | ||
| Anthony Hickey, Chief Officer | ||
| Christopher Cano, COO Devel | ||
| Dale Christensen, Head Devel | ||
| Glenn Mattes, CEO Pres |
Tff Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tff Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (2.27 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Shares Owned By Insiders | 3.31 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 157.16 K | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 0.24 X |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |